Molecule CRO

Molecule CRO: The shift of a large number of clinical trials to emerging markets, including the Middle East and North Africa, has highlighted the need for establishing appropriate infrastructure in the region. Building the capacity to conduct clinical research according to proper ethical and quality standards requires the development, education, and training of researchers in the region. Founded in June 2010, Molecule CRO envisions becoming a leader in the ethical and professional conduct of clinical trials in Jordan and across the Middle East and North Africa, in compliance with international standards.